These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2148622)

  • 21. [Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides].
    Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
    Arch Fr Pediatr; 1991; 48(6):397-403. PubMed ID: 1929726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic rationale for a malarial suppressant administered once monthly.
    Peck CC; Lewis AN; Joyce BE
    Ann Trop Med Parasitol; 1975 Jun; 69(2):141-5. PubMed ID: 1155986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current status of research on the prevention of congenital toxoplasmosis].
    Iygiste AK; Zasukhin DN
    Sov Med; 1971; 34(12):22-7. PubMed ID: 5004616
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention and treatment of materno-fetal toxoplasmosis].
    Fortier B; Ajana F; Pinto de Sousa MI; Aissi E; Camus D
    Presse Med; 1991 Sep; 20(29):1374-83. PubMed ID: 1835012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chloroquine and sulfadoxine/pyrimethamine sensitivity in Burkina Faso. In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Burkina Faso.
    Del Nero L; Nebie I; Soudouem G; Pietra V
    Trop Geogr Med; 1994; 46(1):8-10. PubMed ID: 8165742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Congenital toxoplasmosis with hydrocephalus diagnosed in utero: outcome of treatment].
    Cotty F; Carpentier MA; Descamps P; Perrotin F; Richard-Lenoble D
    Arch Pediatr; 1997 Mar; 4(3):247-50. PubMed ID: 9181018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo response of multi-resistant Plasmodium falciparum infections to mefloquine and its combination with sulfadoxine/pyrimethamine in Cambodia.
    Denis MB; Kouznetsov RL; Giboda M
    Folia Parasitol (Praha); 1991; 38(2):187-8. PubMed ID: 1937278
    [No Abstract]   [Full Text] [Related]  

  • 29. Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis.
    Johannessen JK; Christiansen I; Schmidt DR; Petersen E; Hansen SH
    J Pharm Biomed Anal; 2005 Jan; 36(5):1093-8. PubMed ID: 15620537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Too late prenatal diagnosis of fetal toxoplasmosis: a case report.
    Nowakowska D; Respondek-Liberska M; Golab E; Stray-Pedersen B; Szaflik K; Dzbenski TH; Wilczynski J
    Fetal Diagn Ther; 2005; 20(3):190-3. PubMed ID: 15824496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women.
    Mockenhaupt FP; Bedu-Addo G; Junge C; Hommerich L; Eggelte TA; Bienzle U
    Antimicrob Agents Chemother; 2007 Jan; 51(1):332-4. PubMed ID: 17088491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice.
    Neerja J; Puri SK
    Exp Parasitol; 2004; 107(3-4):120-4. PubMed ID: 15363937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxoplasmosis. A cause of infertility.
    Eckerling B; Neri A; Eylan E
    Fertil Steril; 1968; 19(6):883-91. PubMed ID: 5697306
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro susceptibility of Plasmodium falciparum collected from pyrimethamine-sulfadoxine sensitive and resistant areas in Thailand.
    Sabchareon A; Chongsuphajaisiddhi T; Attanath P; Kanjanapipatkul K; Doberstyn EB; Suebsaeng L
    Bull World Health Organ; 1985; 63(3):597-602. PubMed ID: 3899396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?
    Petersen E; Schmidt DR
    Expert Rev Anti Infect Ther; 2003 Jun; 1(1):175-82. PubMed ID: 15482110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The child with congenital toxoplasmosis.
    McLeod R; Boyer K; Roizen N; Stein L; Swisher C; Holfels E; Hopkins J; Mack D; Karrison T; Patel D; Pfiffner L; Remington J; Withers S; Meyers S; Aitchison V; Mets M; Rabiah P; Meier P
    Curr Clin Top Infect Dis; 2000; 20():189-208. PubMed ID: 10943525
    [No Abstract]   [Full Text] [Related]  

  • 37. Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
    Chemla C; Villena I
    Pediatr Infect Dis J; 2017 Mar; 36(3):349-350. PubMed ID: 28187118
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of toxoplasmosis in the pregnant mother and newborn child.
    Stray-Pedersen B
    Scand J Infect Dis Suppl; 1992; 84():23-31. PubMed ID: 1290070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Reply: Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
    Dupont D; Peyron F
    Pediatr Infect Dis J; 2017 Mar; 36(3):350. PubMed ID: 28187119
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of congenital toxoplasmosis].
    Russo M; Galanti B
    Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.